HNGE - CIK 0001673743
The table below shows Hinge Health, Inc.'s cash flow statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Operating cash flow | $171.44M | $49.00M | -$63.91M |
| Capital expenditure | $708.00K | $1.04M | $1.98M |
| Investing cash flow | -$113.76M | $18.31M | $1.50M |
| Dividends paid | - | - | - |
| Stock buybacks | $65.03M | $0.00 | $0.00 |
| Financing cash flow | -$150.47M | -$2.20M | -$3.00M |
Hinge Health, Inc. reported operating cash flow of $171.44M for fiscal year 2025. That is up 249.9% from $49.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.